Rice Hall James & Associates’s Establishment Labs ESTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.2M Sell
548,674
-102,885
-16% -$7.03M 1.73% 11
2025
Q4
$47.5M Sell
651,559
-108,638
-14% -$6.56M 2.61% 5
2025
Q3
$31.2M Sell
760,197
-77,510
-9% -$3.17M 1.7% 13
2025
Q2
$35.8M Buy
837,707
+10,284
+1% +$359K 1.93% 11
2025
Q1
$33.8M Buy
827,423
+56,756
+7% +$2.12M 1.98% 10
2024
Q4
$35.5M Sell
770,667
-22,633
-3% -$987K 1.95% 9
2024
Q3
$34.3M Buy
793,300
+76,959
+11% +$3.35M 1.86% 10
2024
Q2
$32.6M Sell
716,341
-21,679
-3% -$1.1M 1.95% 11
2024
Q1
$37.6M Sell
738,020
-12,889
-2% -$517K 2.14% 11
2023
Q4
$19.4M Buy
750,909
+382,502
+104% +$11.2M 1.13% 23
2023
Q3
$18.1M Buy
368,407
+107,441
+41% +$6.42M 1.15% 18
2023
Q2
$17.9M Buy
260,966
+135,338
+108% +$9.35M 1.02% 26
2023
Q1
$8.51M Buy
125,628
+91,486
+268% +$6.27M 0.48% 52
2022
Q4
$2.24M Sell
34,142
-804
-2% -$48.6K 0.13% 174
2022
Q3
$1.91M Sell
34,946
-499
-1% -$29.8K 0.11% 191
2022
Q2
$1.93M Buy
35,445
+993
+3% +$63K 0.09% 192
2022
Q1
$2.32M Buy
34,452
+1,039
+3% +$60.8K 0.09% 197
2021
Q4
$2.26M Sell
33,413
-4,535
-12% -$317K 0.08% 205
2021
Q3
$2.72M Buy
37,948
+52
+0.1% +$3.83K 0.1% 157
2021
Q2
$3.31M Sell
37,896
-2,558
-6% -$190K 0.12% 128
2021
Q1
$2.53M Buy
40,454
+12
+0% +$692 0.08% 172
2020
Q4
$1.52M Buy
40,442
+1,661
+4% +$43.8K 0.05% 222
2020
Q3
$719K Buy
38,781
+13,496
+53% +$240K 0.03% 238
2020
Q2
$472K Buy
+25,285
New +$430K 0.02% 244

Other funds holding ESTA

Rice Hall James & Associates's ESTA Position: Q1 2026 in Review

Rice Hall James & Associates reduced its Establishment Labs (ESTA) stake by 16% in Q1 2026, selling an estimated $7.03M and leaving 548,674 shares worth $31.2M. The position accounts for 1.73% of the portfolio, ranked #11.

Rice Hall James & Associates first reported a position in ESTA in Q2 2020 and has held it in 24 quarters since. The position peaked at $47.5M in Q4 2025. 176 funds tracked by Wall St. Rank hold ESTA as of Q1 2026.

  • Rice Hall James & Associates held 548,674 shares of Establishment Labs worth $31.2M as of Q1 2026.
  • Rice Hall James & Associates sold 102,885 Establishment Labs shares in Q1 2026, an estimated $7.03M.
  • Establishment Labs made up 1.73% of Rice Hall James & Associates's portfolio in Q1 2026, its #11 holding.
  • Rice Hall James & Associates first reported a position in Establishment Labs in Q2 2020 and has held it in 24 quarters since.
  • Rice Hall James & Associates's Establishment Labs position peaked at $47.5M in Q4 2025.
  • 176 funds tracked by Wall St. Rank held Establishment Labs as of Q1 2026.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.